| Literature DB >> 25515252 |
Rémi Dulermo1, Heber Gamboa-Meléndez, Stéphanie Michely, France Thevenieau, Cécile Neuvéglise, Jean-Marc Nicaud.
Abstract
Jen proteins in yeast are involved in the uptake of mono/dicarboxylic acids. The Jen1 subfamily transports lactate and pyruvate, while the Jen2 subfamily transports fumarate, malate, and succinate. Yarrowia lipolytica has six JEN genes: YALI0B19470g, YALI0C15488g, YALI0C21406g, YALI0D20108g, YALI0D24607g, and YALI0E32901g. Through phylogenetic analyses, we found that these genes represent a new subfamily, Jen3 and that these three Jen subfamilies derivate from three putative ancestral genes. Reverse transcription-PCR. revealed that only four YLJEN genes are expressed and they are upregulated in the presence of lactate, pyruvate, fumarate, malate, and/or succinate, suggesting that they are able to transport these substrates. Analysis of deletion mutant strains revealed that Jen3 subfamily proteins transport fumarate, malate, and succinate. We found evidence that YALI0C15488 encodes the main transporter because its deletion was sufficient to strongly reduce or suppress growth in media containing fumarate, malate, or succinate. It appears that the other YLJEN genes play a minor role, with the exception of YALI0E32901g, which is important for malate uptake. However, the overexpression of each YLJEN gene in the sextuple-deletion mutant strain ΔYLjen1-6 revealed that all six genes are functional and have evolved to transport different substrates with varying degrees of efficacy. In addition, we found that YALI0E32901p transported succinate more efficiently in the presence of lactate or fumarate.Entities:
Keywords: Fumarate; lactate; malate; succinate; transport; yeast
Mesh:
Substances:
Year: 2014 PMID: 25515252 PMCID: PMC4335979 DOI: 10.1002/mbo3.225
Source DB: PubMed Journal: Microbiologyopen ISSN: 2045-8827 Impact factor: 3.139
Figure 1Alignment of the six YLJen protein sequences with Jen1p and/or Jen2p sequences of Saccharomyces cerevisiae, Kluyveromyces lactis, and Candida albicans, constructed with ClustalW. SC, S. cerevisiae (YKL217W for SCJen1p), CA, C. albicans (CaO19.7447 for CAJen1p; CaO19.12767 for CAJen2p) and KL, K. lactis (KLLA0E16259 for KLJen1p; KLLA0F10043 for KLJen2p). The blue frame contains the NXX(S/T)HX(S/T)QDXXXT motif and the F270 and Q498 residues of S. cerevisiae are indicated by red and green frames, respectively. Yellow-highlighted amino acids represent transmembrane domains predicted by TMHMM. Gray-highlighted amino acids represent putative ubiquitination sites predicted with high confidence by www.ubpred.org. Purple-highlighted amino acids indicate K9 and K338, the experimentally confirmed ubiquitination sites of SCJen1p (Paiva et al. 2009).
Strains and plasmids
| Strain or plasmid | Genotype or other relevant characteristics (name in figures) | Source or reference |
|---|---|---|
| DH5 | Promega | |
| W29 | Barth and Gaillardin ( | |
| Po1d | Barth and Gaillardin ( | |
| JMY330 | Beopoulos et al. ( | |
| JMY2900 | F. Brunel, (unpubl. data) | |
| JMY2946 | Po1d Δ | This study |
| JMY2949 | Po1d | This study |
| JMY2956 | Po1d Δ | This study |
| JMY3007 | Po1d Δ | This study |
| JMY3012 | Po1d Δ | This study |
| JMY3014 | Po1d | This study |
| JMY3018 | Po1d | This study |
| JMY3040 | Po1d | This study |
| JMY3075 | Po1d | This study |
| JMY3084 | Po1d Δ | This study |
| JMY3086 | Po1d Δ | This study |
| JMY3088 | Po1d Δ | This study |
| JMY3090 | Po1d | This study |
| JMY3092 | Po1d | This study |
| JMY3093 | Po1d | This study |
| JMY3094 | Po1d | This study |
| JMY3101 | Po1d | This study |
| JMY3104 | Po1d | This study |
| JMY3106 | Po1d | This study |
| JMY3109 | Po1d | This study |
| JMY3112 | Po1d | This study |
| JMY3146 | JMY3084 + | This study |
| JMY3147 | JMY3086 + | This study |
| JMY3151 | JMY3084 + | This study |
| JMY3152 | JMY3084 + | This study |
| JMY3156 | JMY3088 + | This study |
| JMY3171 | JMY3147 + | This study |
| JMY3209 | JMY3151 + | This study |
| JMY3210 | JMY3156 + | This study |
| JMY3213 | JMY3156 + | This study |
| JMY3215 | JMY3171 Ura− Leu− | This study |
| JMY3249 | JMY3156 + | This study |
| JMY3250 | JMY3151 + | This study |
| JMY3252 | Y3147 + | This study |
| JMY3257 | Po1d + | This study |
| JMY3278 | JMY3257 + | This study |
| JMY3282 | JMY3215 + | This study |
| JMY3333 | JMY3282 + | This study |
| JMY3598 | JMY3282 + | This study |
| JMY3702 | JMY3598 Ura− Leu− | This study |
| JMY3722 | JMY3598 | This study |
| JMY3751 | JMY3722 + p | This study |
| JMY3754 | JMY3722 + p | This study |
| JMY3757 | JMY3722 + p | This study |
| JMY3760 | JMY3722 + p | This study |
| JMY3763 | JMY3722 + p | This study |
| JMY4125 | JMY3702 + p | This study |
| JMY4157 | JMY4125 + | This study |
| Plasmids | ||
| pCR4Blunt-TOPO | Cloning vector | Invitrogen |
| JMP802 | JMP62-pTEF- | |
| JMP803 | JMP62-pTEF- | (Müller et al. |
| JMP547 | pUB4-CRE | Fickers et al. ( |
| JMP1392 | JMP62-p | Kabran et al. ( |
| JMP1647 | pCR4Blunt-TOPO | This study |
| JMP1649 | pCR4Blunt-TOPO | This study |
| JMP1683 | pCR4Blunt-TOPO | This study |
| JMP1684 | pCR4Blunt-TOPO | This study |
| JMP1689 | pCR4Blunt-TOPO | This study |
| JMP1667 | pCR4Blunt-TOPO | This study |
| JMP1671 | pCR4Blunt-TOPO | This study |
| JMP1679 | pCR4Blunt-TOPO | This study |
| JMP1681 | pCR4Blunt-TOPO | This study |
| JMP1698 | pCR4Blunt-TOPO | This study |
| JMP1702 | pCR4Blunt-TOPO | This study |
| JMP1713 | pCR4Blunt-TOPO | This study |
| JMP1715 | pCR4Blunt-TOPO | This study |
| JMP 1792 | JMP62 p | This study |
| JMP1794 | JMP62 p | This study |
| JMP1796 | JMP62 p | This study |
| JMP1798 | JMP62 p | This study |
| JMP1809 | JMP62 p | This study |
| JMP1813 | pCR4Blunt-TOPO | This study |
| JMP2366 | JMP62 p | This study |
Primer list
| Genes | Primers | Sequences | Utilization |
|---|---|---|---|
| B19470UpNotI | GAATGCGGCCGCCAGTTGGTTCAACTGGGTCC | Upstream fragment of | |
| B19470UpIsceI | CGATTACCCTGTTATCCCTACCGGCATGAGAGTGGTGTTTGG | ||
| B19470DnNotI | GAATGCGGCCGCCAGCCAGGTCAGCTACTATT | Downstream fragment of | |
| B19470DnIsceIIceuI | GGTAGGGATAACAGGGTAATCGTAACTATAACGGTCCTAAGGTAGCGACCAATCTCACTCGTTAATTAG | ||
| Ver1B19470 | CAAGTATCATGGTTTGTGGG | Verification of disruption | |
| Ver2B19470 | GTGTCACAACAGTGTCACCC | ||
| StartB19470 | ATCGGATCCCACAATGCCCATCACAGTTTCACAAGAAGTG | Overexpression of | |
| EndB19470 | CATCCTAGGTTAACGAGTGAGATTGGTGTCGATTCG | ||
| B19470F | TCTTCTTCTTGCAGTTCTTTG | Expression of | |
| B19470R | GTGCTCATCGAGAATAGGG | ||
| C15488UpNotI | GAATGCGGCCGCTTTGTCTGTCTTCCCGTTGC | Upstream fragment of | |
| C15488UpIsceI | CGATTACCCTGTTATCCCTACCGGTGAATGAACGAACGAAGAAGG | ||
| C15488DnNotI | GAATGCGGCCGCTGAGAGTCCTTCTGTCTACC | Downstream fragment of | |
| C15488DnIsceIIceuI | GGTAGGGATAACAGGGTAATCGTAACTATAACGGTCCTAAGGTAGCGAGTGTAGCAACTAACGTATTG | ||
| Ver1-1C15488 | CCACTCCTCCTCTCCTTAGACCG | Verification of disruption | |
| Ver2-2C15488 | CCTCTCCATCGATTTCGAGGTGC | ||
| StartC15488 | ATCGGATCCCACAATGGATTTGGACAACCTCCCTGCCCC | Overexpression of | |
| EndC15488 | CATCCTAGGCTACTTAGTAGCATTGGTGTCAACTC | ||
| C15488F | TTCTTCTTGCAGTTCTTCGT | Expression of | |
| C15488R | CGACCCCATTATCATCTTT | ||
| C21406UpNotI | GAATGCGGCCGCGGAGAAAATGGACGTGTGAGACGC | Upstream fragment of | |
| C21406UpIsceI | CGATTACCCTGTTATCCCTACCGAGATAGAGCAAGTAGAAGCAGCG | ||
| C21406DnNotI | GAATGCGGCCGCGGACTTGTAACAGCACACGTTCGC | Downstream fragment of | |
| C21406Dn2IsceIIceuI | GGTAGGGATAACAGGGTAATCGTAACTATAACGGTCCTAAGGTAGCGACTCTGAGACCCTCCCCGGATCCC | ||
| Ver1C21406 | CATTAGCGTGGTTTCCATGCG | Verification of disruption | |
| Ver2C21406 | AAGAGAGTTACTTTTGCGGGAGG | ||
| StartC21406 | ATCGGATCCCACAATGGATCTCGACAACTACCCTCCTC | Overexpression of | |
| EndC21406 | CATCCTAGGTCACTTTTGGGATCCGGGGAGGGTCTC | ||
| C21406F | GATCTTCCATGATTGGTATTG | Expression of | |
| C21406R | CAGGGTGACGACAAAGAG | ||
| D20108UpNotI | GAATGCGGCCGCGCACAAGTAGGTGGGTCCTTCCG | Upstream fragment of | |
| D20108UpIsceI | CGATTACCCTGTTATCCCTACCGACAGATTGAGCGAGTAGACAGG | ||
| D20108DnNotI | GAATGCGGCCGCGAGAATCTGGAAGCATCCTGCTGCC | Downstream fragment of | |
| D20108Dn2IsceIIceuI | GGTAGGGATAACAGGGTAATCGTAACTATAACGGTCCTAAGGTAGCGATAATGTAGGGTGTGTGTGTGACG | ||
| Ver1-2D20108 | CCAAGGGTGGCCATTAGGAGTCG | Verification of disruption | |
| Ver2-2D20108 | GGTGTCATATTCGAGTCCTCGC | ||
| StartD20108-2 | ATCGGATCCCACAATGAATTTTGACAACTTCCCAGCACCAGATCTG | Overexpression of | |
| EndD20108-2 | CATCCTAGGTTATCGAGTATCGCTCGAAGAACGTCTTTCAATGTTC | ||
| D20108F | CTTCTTCTGCTTCTTCAACC | Expression of | |
| D20108R | CATCTCTGCTTGTCTGTTTTC | ||
| D24607UpNotI | GAATGCGGCCGCGATGCAGATCTTTCCGAGCGCTGG | Upstream fragment of | |
| D24607UpIsceI | CGATTACCCTGTTATCCCTACCGGAAGGAGTCTTCCTGTTTATGG | ||
| D24607DnNotI | GAATGCGGCCGCCAAGTGGTTCCTGGACCGAATGGC | Downstream fragment of | |
| D24607Dn2IsceIIceuI | GGTAGGGATAACAGGGTAATCGTAACTATAACGGTCCTAAGGTAGCGAGGCAGGTATTAGATTTATATGAGTAGACG | ||
| Ver1D24607 | CGACATTTGAAGGAGATGACGG | Verification of disruption | |
| Ver2D24607 | GGACATTGTGCCCTGGGCCACC | ||
| StartD24607 | ATCGGATCCCACAATGACCCAGTCGTACGAAGTCGGAAAC | Overexpression of | |
| EndD24607 | CATCCTAGGCTAATGAACACTTCCAACAGTGGTCTG | ||
| HG-RT-D24607F2 | CCGGAGGAATCTTTATGG | Expression of | |
| HG-RT-D24607R2 | GTGAGATGGATGGGGATG | ||
| E32901UpNotI | GAATGCGGCCGCAGAGAGTTCTTTATCCACCCCACGG | Upstream fragment of | |
| E32901UpIsceI | CGATTACCCTGTTATCCCTACCGGACTAGTGAGTGCTTGCCACGAG | ||
| E32901DnNotI | GAATGCGGCCGCCAGTACTCATTACCAGGCAATACGG | Downstream fragment of | |
| E32901Dn2IsceIIceuI | GGTAGGGATAACAGGGTAATCGTAACTATAACGGTCCTAAGGTAGCGACCAATATGACTCCCCCTACGAGTCC | ||
| Ver1 E32901 | CTCAACAAAGAGATGATAAGCC | Verification of disruption | |
| Ver2 E32901 | CTGTATTGAATATTTGACTGCTCC | ||
| StartE32901 | ATCGGATCCCACAATGGAAGCTCCTAATCTCTCGCCAGC | Overexpression of | |
| EndE32901 | CATCCTAGGTTACTTGGACTCGTAGGGGGAGTC | ||
| E32901F | CGGCTCTCAAGACCTCTAC | Expression of | |
| E32901R | GAGCACCTCCAATAACACAA | ||
| pTEF-Start | GGGTATAAAAGACCACCGTCC | Verification of insertion of overexpression cassettes | |
| 61 Stop | GTAGATAGTTGAGGTAGAAGTTG | ||
| ACT-A1 | TCCAGGCCGTCCTCTCCC | Expression of | |
| ACT-A2 | GGCCAGCCATATCGAGTCGCA |
Percentage of shared amino acids between YLJenp and the Jen1p and Jen2p of Saccharomyces cerevisiae, Candida albicans, and Kluyveromyces lactis
Figure 2Phylogenetic trees of the Jen protein family. Trees are based on an alignment of Jen proteins and reconstructed with the Neighbor-Joining algorithm. A. Phylogeny of 61 Jen proteins from 18 hemiascomycetous species as inferred from 405 amino acid residues. Each subfamily of Jen proteins is surrounded by a different color: blue for Jen1p, green for Jen2p, and pink for Jen3p. The orange oval indicates the 28 Jen proteins found in the Yarrowia clade. Protein names in bold refer to protein from which experimental data have been published. B. Detailed phylogeny of 28 Jen proteins from the Yarrowia clade as inferred from an alignment of 423 amino acid residues. KLJen2p was used as an outgroup.
Figure 3Expression profiles of YLJEN genes of reference strain JMY2900 in the presence of glucose, fumarate, lactate, malate, pyruvate, or succinate. Strain precultures were grown in liquid YNB supplemented with 1% glucose and 0.5% yeast extract for 15 h at 28°C (T0) and then transferred into fresh liquid YNB media supplemented with 1% glucose (G), 0.3% fumarate (F), 0.3% lactate (L), 0.3% malate (M), 0.3% pyruvate (P), or 0.3% succinate (S). RT-PCR was performed from cells incubated after 2 h post-inoculation. Actin was used as an endogenous control for all conditions tested. RT- and gDNA represent negative and positive controls, respectively.
Figure 4Growth of various YLJEN-deletion strains in media which contained 0.3% fumarate, malate, or succinate. (A and D) Growth in fumarate medium. (B and E) Growth in malate medium. (C and F) Growth in succinate medium. Growth curves are representative of three independent tests.
Figure 5Growth of YLJEN-overexpression ΔYLjen1-6 mutants on media containing 0.3% fumarate, malate, or succinate. Growth curves are representative of three independent tests.
Figure 6Growth and carbon-source consumption of reference strain JMY2900; YLJEN1-, YLJEN6-, and YLJEN1,6-deletion mutants; and YLJEN-overexpression strains. Strains were grown on media which contained fumarate, lactate, malate, or succinate, and three patterns of strain behavior were observed, presented here in A, B, and C, respectively. Growth and consumption curves are representative of three independent tests.
Substrate consumption rates of the different strains
| Fumarate | Malate | Succinate | Lactate | |||||
|---|---|---|---|---|---|---|---|---|
| Rate (g L−1 h−1) |
| Rate (g L−1 h−1) |
| Rate (g L−1 h−1) |
| Rate (g L−1 h−1) |
| |
| Reference strain JMY2900 | 0.22 (1) | 0.98 | 0.24 (1) | 0.96 | 0.19 (1) | 0.97 | 0.21 (1) | 0.91 |
| Δ | 0.28 (1.2) | 0.99 | 0.29 (1.2) | 0.95 | 0.18 (0.95) | 0.99 | 0.20 (0.94) | 0.99 |
| 0.24 (1.1) | 0.99 | 0.27 (1.13) | 0.99 | 0.21 (1.1) | 0.97 | 0.20 (1.1) | 0.92 | |
| 0.19 (0.88) | 0.96 | 0.29 (1.2) | 0.99 | 0.17 (0.86) | 0.99 | 0.24 (0.86) | 0.99 | |
| 0.26 (1.2) | 0.99 | 0.18 (0.74) | 1 | 0.29 (1.52) | 0.94 | 0.16 (0.77) | 0.98 | |
| 0.24 (1.1) | 0.99 | 0.16 (0.65) | 0.96 | 0.23 (1.2) | 0.97 | 0.12 (0.57) | 0.96 | |
| 0.22 (1) | 1 | 0.10 (0.44) | 0.97 | 0.27 (1.4) | 0.94 | 0.18 (0.85) | 0.99 | |
| 0.16 (0.74) | 0.990.99 | 0.12 (0.49) | 10.99 | 0.2 (1.05) | 1 | 0.25 (1.14) | 0.96 | |
Values in parenthesis indicate ratio of rate of mutant to rate of reference strain, that is rate of substrate consumption before (*) and after (**) 22 h of growth. The results represent the mean values of at least two independent experiments and SD did not exceed 7%. R2 corresponds to the coefficient of linear correlation.
Figure 7Growth and carbon-source consumption of the YLJEN6-overexpression strain when grown on media which contained, alone or in mixture, fumarate, lactate, malate, and/or succinate. (A) Growth in media containing fumarate (Fum), lactate (Lac), malate (Mal), or succinate (Suc). (B) Substrate consumption in media containing fumarate (Fum), lactate (Lac), malate (Mal), or succinate (Suc). (C) Growth in media containing lactate and fumarate (FL), lactate and malate (ML), or lactate and succinate (SL). (D) Substrate consumption in media containing lactate and fumarate. (E) Substrate consumption in media containing lactate and malate. (F) Substrate consumption in media containing lactate and succinate. (G) Growth in media containing fumarate and malate (FM) or fumarate and succinate (FS). (H) Substrate consumption in media containing fumarate and malate (I) Substrate consumption in media containing fumarate and succinate.